In this presentation given at Ending Age-Related Diseases 2020, Dr. Tyler Golato talked about his company, Molecule, highlighting the current problems with pharmaceutical development and offering a new, decentralized method of developing therapies. He discussed the well-known valley of death, the gap between the basic research of academia and the later-stage development of pharmaceutical companies. Dr. Golato advertises Molecule as a method of fostering collaboration between early developers and pharmaceutical companies in order to bridge this gap, particularly in the context of rejuvenation biotechnology.
Tyler Gelato on Decentralized Development at EARD2020
Molecule might be a key player in bridging the valley of death.

Write a comment: